Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-20-004900)

Filing Details

Accession Number:: 0000899243-20-004900
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-02-18 16:55:11
Reporting Period:: 2020-02-14

Accepted Time:: 2020-02-18 16:55:11
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1346302	Xeris Pharmaceuticals Inc	XERS	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1289407	M. Barry Deutsch	C/O Xeris Pharmaceuticals, Inc. 180 N. Lasalle Street, Suite 1600 Chicago IL 60601	See Remarks	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-02-14	9,639	$4.15	39,359	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

Represents shares purchased in an underwritten public offering of the Issuer at the public offering price of $4.15 per share.